Podolanczuk Anna MD is categorized under Business Services (Unclassified) in New York City, NY and active since 2013.
Podolanczuk Anna MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Anna Podolanczuk at the company’s single location by writing to 310 West 95th St Apartment 7e, New York City, New York NY 10025 or by phoning (917) 270-3237. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Podolanczuk Anna MD |
Contact Person: | Anna Podolanczuk |
Address: | 310 West 95th St Apartment 7e, New York City, New York 10025 |
Phone Number: | (917) 270-3237 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Services (Unclassified) |
SIC Code: | 7389 |
NAICS Code: | 561499 |
Share This Business: |
Podolanczuk Anna MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Anna Podolanczuk for inquiries that concern Podolanczuk Anna MD by calling the company number (917) 270-3237, as your correspondence is most welcome. Additionally, the physical location of the single location of Podolanczuk Anna MD can be found at the coordinates 40.79491,-73.974531 as well as the street address 310 West 95th St Apartment 7e in New York City, New York 10025.
For its online presence, you may visit Podolanczuk Anna MD’s website at and engage with its social media outlets through on Twitter and on Facebook.